Literature DB >> 8878478

Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

A Joutel1, C Corpechot, A Ducros, K Vahedi, H Chabriat, P Mouton, S Alamowitch, V Domenga, M Cécillion, E Marechal, J Maciazek, C Vayssiere, C Cruaud, E A Cabanis, M M Ruchoux, J Weissenbach, J F Bach, M G Bousser, E Tournier-Lasserve.   

Abstract

Stroke is the third leading cause of death, and vascular dementia the second cause of dementia after Alzheimer's disease. CADASIL (for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) causes a type of stroke and dementia whose key features include recurrent subcortical ischaemic events and vascular dementia and which is associated with diffuse white-matter abnormalities on neuroimaging. Pathological examination reveals multiple small, deep cerebral infarcts, a leukoencephalopathy, and a non-atherosclerotic, non-amyloid angiopathy involving mainly the small cerebral arteries. Severe alterations of vascular smooth-muscle cells are evident on ultrastructural analysis. We have previously mapped the mutant gene to chromosome 19. Here we report the characterization of the human Notch3 gene which we mapped to the CADASIL critical region. We have identified mutations in CADASIL patients that cause serious disruption of this gene, indicating that Notch3 could be the defective protein in CADASIL patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878478     DOI: 10.1038/383707a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  495 in total

1.  Chromosomal localization, genomic characterization, and mapping to the Noonan syndrome critical region of the human Deltex (DTX1) gene.

Authors:  L Lee; J Dowhanick-Morrissette; A Katz; L Jukofsky; I D Krantz
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

2.  CADASIL: Notch signaling defect or protein accumulation problem?

Authors:  N B Spinner
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Notch signaling is essential for vascular morphogenesis in mice.

Authors:  L T Krebs; Y Xue; C R Norton; J R Shutter; M Maguire; J P Sundberg; D Gallahan; V Closson; J Kitajewski; R Callahan; G H Smith; K L Stark; T Gridley
Journal:  Genes Dev       Date:  2000-06-01       Impact factor: 11.361

4.  Hes1 and Hes5 as notch effectors in mammalian neuronal differentiation.

Authors:  T Ohtsuka; M Ishibashi; G Gradwohl; S Nakanishi; F Guillemot; R Kageyama
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

5.  CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand.

Authors:  Talin Haritunians; Jim Boulter; Carol Hicks; Jonathon Buhrman; Guy DiSibio; Carrie Shawber; Gerry Weinmaster; Donna Nofziger; Carolyn Schanen
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

6.  SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation.

Authors:  G Wu; S Lyapina; I Das; J Li; M Gurney; A Pauley; I Chui; R J Deshaies; J Kitajewski
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  Notch signaling during vascular development.

Authors:  T Gridley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

8.  Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects.

Authors:  Sarbjit S Nijjar; Lorraine Wallace; Heather A Crosby; Stefan G Hubscher; Alastair J Strain
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 9.  New advances in identifying genetic anomalies in stroke-prone probands.

Authors:  James F Meschia; Bradford B Worrall
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

10.  CADASIL: how to avoid the unavoidable?

Authors:  Montserrat G Delgado; Elicer Coto; Alberto Tuñon; Antonio Sáiz
Journal:  BMJ Case Rep       Date:  2011-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.